A pilot randomised controlled trial: Joint Walkers, a Group of Rheumatology Outdoor Walkers(GROW Study)

Not Applicable

• Conditions: musculoskeletal pain; Musculoskeletal - Osteoarthritis; Inflammatory and Immune System - Autoimmune diseases; Musculoskeletal - Osteoporosis; Inflammatory and Immune System - Rheumatoid arthritis; Inflammatory and Immune System - Connective tissue diseases; Inflammatory and Immune System - Other inflammatory or immune system disorders; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12621000945820
• Lead Sponsor: iverpool Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-07-19
• Last Update Posted: 17 August 2021

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 62

Inclusion Criteria

•Over the age of 18
•Consulted Rheumatology Physiotherapy service at Liverpool Hospital
•Independently mobile in the community
•Medically cleared to attend Joint Walkers
•Can communicate with staff in English or are able to bring a bilingual support person to their walking session (should they be allocated to this arm)
•Have the cognitive capacity to give informed consent
•Available twice a week to attend a walking group for 3 months

Exclusion Criteria

•Unable to navigate the community independently
•Unable to safely communicate with staff or bring a bilingual support person.
•Unavailable to attend a walking group twice a week
•Condition medically unstable
•Condition with a prognosis of functionally deterioration over the next 3 months deeming patient unsafe to complete program
•Lack capacity to provide consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Composite primary outcome of feasibility<br>Assessed by: number participants recruited each month, proportion of eligible patients recruited per month, retention of participants in both arms of the study and adherence to completion of the intervention.<br><br><br><br>[3 & 6 months post commencement of the intervention];Primary clinical outcome: Change in walking activity, as measured using the subscale Walking Activity, using the Incidental and planned exercise questionnaire, version W .[3 & 6 months from commencement of treatment]

Secondary Outcome Measures

Name	Time	Method
Achievement of physical activity guidelines, as measured using the Incidental and planned exercise questionnaire, version W<br>[3 & 6 months after commencement of the intervention];Changes in self-efficacy with exercise, as measured using Self-Efficacy with Exercise Scale <br><br> [3 & 6 month after commencement of intervention];Experiences of Social Cohesion as measured using The Physical Activity Group Environment Questionnaire <br>[3 & 6 months after commencement of treatment];Participant feedback regarding the acceptability of the intervention via a 20 minute open ended phone interview[3 months post start of intervention]